| Year |
Citation |
Score |
| 2002 |
Naranda T, Kaufman RI, Li J, Wong K, Boge A, Hallén D, Fung KY, Duncan MW, Andersen N, Goldstein A, Olsson L. Activation of erythropoietin receptor through a novel extracellular binding site. Endocrinology. 143: 2293-302. PMID 12021194 DOI: 10.1210/Endo.143.6.8860 |
0.308 |
|
| 1997 |
Naranda T, Goldstein A, Olsson L. A peptide derived from an extracellular domain selectively inhibits receptor internalization: Target sequences on insulin and insulin-like growth factor 1 receptors Proceedings of the National Academy of Sciences of the United States of America. 94: 11692-11697. PMID 9326672 DOI: 10.1073/pnas.94.21.11692 |
0.354 |
|
| 1994 |
Xie GX, Meng F, Mansour A, Thompson RC, Hoversten MT, Goldstein A, Watson SJ, Akil H. Primary structure and functional expression of a guinea pig kappa opioid (dynorphin) receptor. Proceedings of the National Academy of Sciences of the United States of America. 91: 3779-83. PMID 8170987 DOI: 10.1073/Pnas.91.9.3779 |
0.409 |
|
| 1994 |
Olsson L, Goldstein A, Stagsted J. Regulation of receptor internalization by the major histocompatibility complex class I molecule Proceedings of the National Academy of Sciences of the United States of America. 91: 9086-9090. PMID 8090774 DOI: 10.1073/pnas.91.19.9086 |
0.33 |
|
| 1993 |
Stagsted J, Mapelli C, Meyers C, Matthews BW, Anfinsen CB, Goldstein A, Olsson L. Amino acid residues essential for biological activity of a peptide derived from a major histocompatibility complex class I antigen. Proceedings of the National Academy of Sciences of the United States of America. 90: 7686-90. PMID 8356070 DOI: 10.1073/Pnas.90.16.7686 |
0.322 |
|
| 1993 |
Meng F, Xie GX, Thompson RC, Mansour A, Goldstein A, Watson SJ, Akil H. Cloning and pharmacological characterization of a rat kappa opioid receptor. Proceedings of the National Academy of Sciences of the United States of America. 90: 9954-8. PMID 8234341 DOI: 10.1073/Pnas.90.21.9954 |
0.303 |
|
| 1992 |
Xie GX, Miyajima A, Goldstein A. Expression cloning of cDNA encoding a seven-helix receptor from human placenta with affinity for opioid ligands Proceedings of the National Academy of Sciences of the United States of America. 89: 4124-4128. PMID 1315051 DOI: 10.1073/Pnas.89.9.4124 |
0.418 |
|
| 1991 |
Goldstein A. Heroin addiction: Neurobiology, pharmacology, and policy† Journal of Psychoactive Drugs. 23: 123-133. PMID 1662715 DOI: 10.1080/02791072.1991.10472231 |
0.356 |
|
| 1990 |
Stagsted J, Reaven GM, Hansen T, Goldstein A, Olsson L. Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen Cell. 62: 297-307. PMID 2196997 DOI: 10.1016/0092-8674(90)90367-N |
0.314 |
|
| 1990 |
Xie GX, Miyajima A, Yokota T, Arai KI, Goldstein A. Chimeric opioid peptides: Tools for identifying opioid receptor types Proceedings of the National Academy of Sciences of the United States of America. 87: 3180-3184. PMID 2158105 DOI: 10.1073/Pnas.87.8.3180 |
0.446 |
|
| 1990 |
Goldstein A, Naidu A. Dextrorphan binds to opioid receptors in guinea-pig brain membranes and is an antagonist at opioid receptors in myenteric plexus Proceedings of the National Academy of Sciences of the United States of America. 87: 1629-1632. PMID 2155421 DOI: 10.1073/Pnas.87.5.1629 |
0.439 |
|
| 1989 |
Hansen T, Stagsted J, Pedersen L, Roth RA, Goldstein A, Olsson L. Inhibition of insulin receptor phosphorylation by peptides derived from major histocompatibility complex class I antigens Proceedings of the National Academy of Sciences of the United States of America. 86: 3123-3126. PMID 2566166 DOI: 10.1073/Pnas.86.9.3123 |
0.301 |
|
| 1988 |
Weitz CJ, Lowney LI, Faull KF, Feistner G, Goldstein A. 6-Acetylmorphine: a natural product present in mammalian brain. Proceedings of the National Academy of Sciences of the United States of America. 85: 5335-8. PMID 3393541 DOI: 10.1073/Pnas.85.14.5335 |
0.619 |
|
| 1988 |
Goldstein A, Nestor JJ, Naidu A, Newman SR. 'DAKLI': A multipurpose ligand with high affinity and selectivity for dynorphin (κ opioid) binding sites Proceedings of the National Academy of Sciences of the United States of America. 85: 7375-7379. PMID 2902630 DOI: 10.1073/Pnas.85.19.7375 |
0.417 |
|
| 1988 |
Sibinga NES, Goldstein A. Opioid peptides and opioid receptors in cells of the immune system Annual Review of Immunology. 6: 219-249. PMID 2838048 DOI: 10.1146/ANNUREV.IY.06.040188.001251 |
0.33 |
|
| 1987 |
Weitz CJ, Faull KF, Goldstein A. Synthesis of the skeleton of the morphine molecule by mammalian liver. Nature. 330: 674-7. PMID 3683586 DOI: 10.1038/330674A0 |
0.63 |
|
| 1986 |
Barrett RW, James IF, Goldstein A. Comparative immuno-removal: A novel method for estimating the concentration of an unknown immunoreactive compound Biochemical and Biophysical Research Communications. 137: 316-322. PMID 3521606 DOI: 10.1016/0006-291X(86)91212-X |
0.302 |
|
| 1986 |
Weitz CJ, Lowney LI, Faull KF, Feistner G, Goldstein A. Morphine and codeine from mammalian brain. Proceedings of the National Academy of Sciences of the United States of America. 83: 9784-8. PMID 3467337 DOI: 10.1073/Pnas.83.24.9784 |
0.606 |
|
| 1986 |
Devi L, Goldstein A. Opioid and other peptides as inhibitors of leumorphin (dynorphin B-29) converting activity Peptides. 7: 87-90. PMID 3012492 DOI: 10.1016/0196-9781(86)90066-5 |
0.358 |
|
| 1985 |
Goldstein A, Barrett RW, James IF, Lowney LI, Weitz CJ, Knipmeyer LL, Rapoport H. Morphine and other opiates from beef brain and adrenal. Proceedings of the National Academy of Sciences of the United States of America. 82: 5203-7. PMID 3860854 DOI: 10.1073/pnas.82.15.5203 |
0.64 |
|
| 1985 |
Civelli O, Douglass J, Goldstein A, Herbert E. Sequence and expression of the rat prodynorphin gene. Proceedings of the National Academy of Sciences of the United States of America. 82: 4291-5. PMID 3858883 DOI: 10.1073/Pnas.82.12.4291 |
0.311 |
|
| 1985 |
Barrett RW, Goldstein A. A monoclonal antibody specific for a dynorphin precursor Neuropeptides. 6: 113-120. PMID 2860615 DOI: 10.1016/0143-4179(85)90102-7 |
0.346 |
|
| 1984 |
Cox BM, Goldstein A, Nelson WT. Nicotine self-administration in rats. British Journal of Pharmacology. 83: 49-55. PMID 6487896 DOI: 10.1111/J.1476-5381.1984.Tb10118.X |
0.509 |
|
| 1984 |
Han JS, Xie GX, Goldstein A. Analgesia induced by intrathecal injection of dynorphin B in the rat Life Sciences. 34: 1573-1579. PMID 6371415 DOI: 10.1016/0024-3205(84)90612-X |
0.386 |
|
| 1984 |
Chavkin C, Goldstein A. Opioid receptor reserve in normal and morphine-tolerant guinea pig ileum myenteric plexus. Proceedings of the National Academy of Sciences of the United States of America. 81: 7253-7. PMID 6095280 DOI: 10.1073/Pnas.81.22.7253 |
0.611 |
|
| 1984 |
Goldstein A, James IF. Multiple opioid receptors criteria for identification and classification Trends in Pharmacological Sciences. 5: 503-505. DOI: 10.1016/0165-6147(84)90527-3 |
0.369 |
|
| 1983 |
Goldstein A. Some thoughts about endogenous opioids and addiction Drug and Alcohol Dependence. 11: 11-14. PMID 6303738 DOI: 10.1016/0376-8716(83)90088-1 |
0.332 |
|
| 1983 |
McGinty JF, Henriksen SJ, Goldstein A, Terenius L, Bloom FE. Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 80: 589-93. PMID 6132379 DOI: 10.1073/pnas.80.2.589 |
0.467 |
|
| 1983 |
Watson SJ, Khachaturian H, Taylor L, Fischli W, Goldstein A, Akil H. Pro-dynorphin peptides are found in the same neurons throughout rat brain: immunocytochemical study. Proceedings of the National Academy of Sciences of the United States of America. 80: 891-4. PMID 6131416 DOI: 10.1073/Pnas.80.3.891 |
0.402 |
|
| 1982 |
Cone RI, Goldstein A. A specific radioimmunoassay for the opioid peptide dynorphin B in neural tissues Neuropeptides. 3: 97-106. PMID 7162565 DOI: 10.1016/0143-4179(82)90005-1 |
0.391 |
|
| 1982 |
McGinty JF, Henriksen SJ, Goldstein A, Terenius L, Bloom FE. Opioid peptide identity and localization in hippocampus. Life Sciences. 31: 1797-800. PMID 6759828 DOI: 10.1016/0024-3205(82)90213-2 |
0.474 |
|
| 1982 |
Chavkin C, Goldstein A. Reduction in opiate receptor reserve in morphine tolerant guinea pig ilea. Life Sciences. 31: 1687-90. PMID 6296572 DOI: 10.1016/0024-3205(82)90186-2 |
0.608 |
|
| 1982 |
Khachaturian H, Watson SJ, Lewis ME, Coy D, Goldstein A, Akil H. Dynorphin immunocytochemistry in the rat central nervous system. Peptides. 3: 941-54. PMID 6132365 DOI: 10.1016/0196-9781(82)90063-8 |
0.352 |
|
| 1982 |
James IF, Chavkin C, Goldstein A. Preparation of brain membranes containing a single type of opioid receptor highly selective for dynorphin. Proceedings of the National Academy of Sciences of the United States of America. 79: 7570-4. PMID 6130527 DOI: 10.1073/Pnas.79.23.7570 |
0.582 |
|
| 1982 |
Fischli W, Goldstein A, Hunkapiller MW, Hood LE. Two "big" dynorphins from porcine pituitary Life Sciences. 31: 1769-1772. PMID 6130436 DOI: 10.1016/0024-3205(82)90206-5 |
0.357 |
|
| 1982 |
Watson SJ, Khachaturian H, Akil H, Coy DH, Goldstein A. Comparison of the distribution of dynorphin systems and enkephalin systems in brain. Science (New York, N.Y.). 218: 1134-6. PMID 6128790 DOI: 10.1126/Science.6128790 |
0.401 |
|
| 1982 |
James IF, Chavkin C, Goldstein A. Selectivity of dynorphin for kappa opioid receptors. Life Sciences. 31: 1331-4. PMID 6128656 DOI: 10.1016/0024-3205(82)90374-5 |
0.617 |
|
| 1982 |
Cone RI, Goldstein A. A dynorphin-like opioid in the central nervous system of an amphibian Proceedings of the National Academy of Sciences of the United States of America. 79: 3345-3349. PMID 6124969 DOI: 10.1073/Pnas.79.10.3345 |
0.406 |
|
| 1982 |
Chavkin C, James IF, Goldstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science (New York, N.Y.). 215: 413-5. PMID 6120570 DOI: 10.1126/Science.6120570 |
0.624 |
|
| 1982 |
Chavkin C, James IF, Goldstein A. Dynorphin is a specific endogenous ligand of the κ opioid receptor Pain. 14: 201. DOI: 10.1016/0304-3959(82)90120-8 |
0.603 |
|
| 1982 |
Leslie FM, Goldstein A. Degradation of dynorphin-(1-13) by membrane-bound rat brain enzymes Neuropeptides. 2: 185-196. DOI: 10.1016/0143-4179(82)90051-8 |
0.37 |
|
| 1981 |
Chavkin C, Goldstein A. Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexus. Nature. 291: 591-3. PMID 6264311 DOI: 10.1038/291591a0 |
0.638 |
|
| 1981 |
Dent RR, Guilleminault C, Albert LH, Posner BI, Cox BM, Goldstein A. Diurnal rhythm of plasma immunoreactive beta-endorphin and its relationship to sleep stages and plasma rhythms of cortisol and prolactin. The Journal of Clinical Endocrinology and Metabolism. 52: 942-7. PMID 6262357 DOI: 10.1210/Jcem-52-5-942 |
0.501 |
|
| 1981 |
Botticelli LJ, Cox BM, Goldstein A. Immunoreactive dynorphin in mammalian spinal cord and dorsal root ganglia. Proceedings of the National Academy of Sciences of the United States of America. 78: 7783-6. PMID 6121324 |
0.448 |
|
| 1981 |
Goldstein A, Fischli W, Lowney LI, Hunkapiller M, Hood L. Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide Proceedings of the National Academy of Sciences of the United States of America. 78: 7219-7223. PMID 6118870 DOI: 10.1073/Pnas.78.11.7219 |
0.378 |
|
| 1981 |
Chavkin C, Goldstein A. Specific receptor for the opioid peptide dynorphin: structure--activity relationships. Proceedings of the National Academy of Sciences of the United States of America. 78: 6543-7. PMID 6118865 DOI: 10.1073/Pnas.78.10.6543 |
0.625 |
|
| 1981 |
Herman BH, Goldstein A. Cataleptic effects of dynorphin-(1-13) in rats made tolerant to a mu opiate receptor agonist Neuropeptides. 2: 13-22. DOI: 10.1016/0143-4179(81)90047-0 |
0.352 |
|
| 1980 |
Judson BA, Himmelberger DU, Goldstein A. The naloxone test for opiate dependence Clinical Pharmacology & Therapeutics. 27: 492-501. PMID 7357808 DOI: 10.1038/Clpt.1980.69 |
0.322 |
|
| 1980 |
Herman BH, Leslie F, Goldstein A. Behavioral effects and in vivo degradation of intraventricularly administered dynorphin-(1-13) and D-Ala2-dynorphin-(1-11) in rats Life Sciences. 27: 883-892. PMID 7191035 DOI: 10.1016/0024-3205(80)90084-3 |
0.394 |
|
| 1980 |
Ghazarossian VE, Dent RR, Otsu K, Ross M, Cox B, Goldstein A. Development and validation of a sensitive radioimmunoassay for naturally occurring beta-endorphin-like peptides in human plasma. Analytical Biochemistry. 102: 80-9. PMID 6153517 DOI: 10.1016/0003-2697(80)90321-8 |
0.533 |
|
| 1980 |
Cox BM, Ghazarossian VE, Goldstein A. Levels of immunoreactive dynorphin in brain and pituitary of Brattleboro rats. Neuroscience Letters. 20: 85-8. PMID 6133255 DOI: 10.1016/0304-3940(80)90238-4 |
0.602 |
|
| 1980 |
Goldstein A, Ghazarossian VE. Immunoreactive dynorphin in pituitary and brain. Proceedings of the National Academy of Sciences of the United States of America. 77: 6207-6210. PMID 6108564 DOI: 10.1073/Pnas.77.10.6207 |
0.393 |
|
| 1980 |
Ghazarossian VE, Chavkin C, Goldstein A. A specific radioimmunoassay for the novel opioid peptide dynorphin. Life Sciences. 27: 75-86. PMID 6105608 DOI: 10.1016/0024-3205(80)90021-1 |
0.607 |
|
| 1980 |
Ho WKK, Cox BM, Chavkin C, Goldstein A. Opioid peptide dynorphin-(1–13): Adsorptive losses and potency estimates Neuropeptides. 1: 143-152. DOI: 10.1016/0143-4179(80)90017-7 |
0.581 |
|
| 1980 |
Ho WKK, Cox BM, Chavkin C, Goldstein A. Opioid peptide dynorphin-(1-13): Adsorptive losses and potency estimates Neuropeptides. 1: 143-152. |
0.667 |
|
| 1979 |
Baizman ER, Cox BM, Osman OH, Goldstein A. Experimental alterations of endorphin levels in rat pituitary. Neuroendocrinology. 28: 402-14. PMID 572491 |
0.524 |
|
| 1979 |
Goldstein A, Tachibana S, Lowney LI, Hunkapiller M, Hood L. Dynorphin-(1-13), an extraordinarily potent opioid peptide Proceedings of the National Academy of Sciences of the United States of America. 76: 6666-6670. PMID 230519 DOI: 10.1073/Pnas.76.12.6666 |
0.457 |
|
| 1979 |
Lowney LI, Gentleman SB, Goldstein A. A pituitary endorphin with novel properties Life Sciences. 24: 2377-2384. PMID 225623 DOI: 10.1016/0024-3205(79)90536-8 |
0.448 |
|
| 1979 |
Cox BM, Ross M, Goldstein A, Palmour RM. Pharmacological and immunological characterization of the Leu5 analogue of human beta-endorphin. Brain Research. 165: 311-9. PMID 217494 DOI: 10.1016/0006-8993(79)90562-6 |
0.532 |
|
| 1978 |
Gentleman S, Lowney LI, Cox BM, Goldstein A. Rapid purification of beta-endorphin by high-performance liquid chromatography. Journal of Chromatography. 153: 274-8. PMID 659560 DOI: 10.1016/S0021-9673(00)89885-4 |
0.494 |
|
| 1978 |
Ross M, Ghazarossian V, Cox BM, Goldstein A. Radioimmunoassays for beta-endorphin: comparison of properties of two antisera. Life Sciences. 22: 1123-30. PMID 566365 DOI: 10.1016/0024-3205(78)90081-4 |
0.594 |
|
| 1978 |
Goldstein A, Naidu A. Opioid activity of a benzomorphan lacking an oxygen atom Biochemical Pharmacology. 27: 1033-1036. PMID 207286 DOI: 10.1016/0006-2952(78)90154-5 |
0.341 |
|
| 1978 |
Goldstein A, Grevert P. Placebo analgesia, endorphins, and naloxone. The Lancet. 312: 1385-1385. PMID 82889 DOI: 10.1016/S0140-6736(78)92026-3 |
0.364 |
|
| 1977 |
Goldstein A, Cox BM. Opioid peptides (endorphins) in pituitary and brain. Psychoneuroendocrinology. 2: 11-6. PMID 905473 DOI: 10.1016/0306-4530(77)90027-0 |
0.609 |
|
| 1977 |
Ross M, Dingledine R, Cox BM, Goldstein A. Distribution of endorphins (peptides with morphine-like pharmacological activity) in pituitary. Brain Research. 124: 523-32. PMID 851863 DOI: 10.1016/0006-8993(77)90951-9 |
0.68 |
|
| 1977 |
Cheung AL, Stavinoha WB, Goldstein A. Endorphins in brains of decapitated and microwave-killed mice Life Sciences. 20: 1285-1289. PMID 850478 DOI: 10.1016/0024-3205(77)90504-5 |
0.367 |
|
| 1977 |
Grevert P, Goldstein A. Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects Proceedings of the National Academy of Sciences of the United States of America. 74: 1291-1294. PMID 322152 DOI: 10.1073/Pnas.74.3.1291 |
0.314 |
|
| 1977 |
Goldstein A, Cox BM, Klee WA, Nirenberg M. Endorphin from pituitary inhibits cyclic AMP formation in homogenates of neuroblastoma X glioma hybrid cells. Nature. 265: 362-3. PMID 189215 DOI: 10.1038/265362A0 |
0.556 |
|
| 1977 |
Goldstein A, Cox BM, Gentleman S, Lowney LI, Cheung AL. PITUITARY AND BRAIN OPIOID PEPTIDES (ENDORPHINS) Annals of the New York Academy of Sciences. 297: 108-114. DOI: 10.1111/J.1749-6632.1977.Tb41848.X |
0.632 |
|
| 1977 |
Goldstein A. Opioid peptides (endorphins) in pituitary and brain Pain. 3: 281. DOI: 10.1016/0304-3959(77)90009-4 |
0.444 |
|
| 1976 |
Goldstein A, Pryor GT, Otis LS, Larsen F. On the role of endogenous opioid peptides: Failure of naloxone to influence shock escape threshold in the rat Life Sciences. 18: 599-604. PMID 1263743 DOI: 10.1016/0024-3205(76)90339-8 |
0.315 |
|
| 1976 |
Cox BM, Goldstein A, Hi CH. Opioid activity of a peptide, beta-lipotropin-(61-91), derived from beta-lipotropin. Proceedings of the National Academy of Sciences of the United States of America. 73: 1821-3. PMID 1064855 |
0.564 |
|
| 1976 |
Goldstein A. Opioid peptides (endorphins) in pituitary and brain. Studies on opiate receptors have led to identification of endogenous peptides with morphine like actions Science. 193: 1081-1086. PMID 959823 DOI: 10.1126/Science.959823 |
0.421 |
|
| 1976 |
Cheung AL, Goldstein A. Failure of hypophysectomy to alter brain content of opioid peptides (endorphins) Life Sciences. 19: 1005-1008. PMID 186675 DOI: 10.1016/0024-3205(76)90291-5 |
0.401 |
|
| 1976 |
Cox BM, Gentleman S, Su TP, Goldstein A. Further characterization of morphine-like peptides (endorphins) from pituitary. Brain Research. 115: 285-96. PMID 10049 DOI: 10.1016/0006-8993(76)90513-8 |
0.627 |
|
| 1975 |
Goldstein A, Goldstein JS, Cox BM. A synthetic peptide with morphine-like pharmacologic action. Life Sciences. 17: 1643-54. PMID 1207378 DOI: 10.1016/0024-3205(75)90109-5 |
0.641 |
|
| 1975 |
Goldstein A, Lowery PJ. Effect of the opiate antagonist naloxone on body temperature in rats. Life Sciences. 17: 927-931. PMID 1195988 DOI: 10.1016/0024-3205(75)90445-2 |
0.396 |
|
| 1975 |
Teschemacher H, Opheim KE, Cox BM, Goldstein A. A peptide-like substance from pituitary that acts like morphine. I. Isolation. Life Sciences. 16: 1771-5. PMID 1171343 |
0.575 |
|
| 1975 |
Schulz R, Goldstein A. Irreversible alteration of opiate receptor function by a photoaffinity labelling reagent. Life Sciences. 16: 1843-1848. PMID 1152614 DOI: 10.1016/0024-3205(75)90288-X |
0.335 |
|
| 1975 |
Cox BM, Opheim KE, Teschemacher H, Goldstein A. A peptide-like substance from pituitary that acts like morphine. 2. Purification and properties. Life Sciences. 16: 1777-82. PMID 1152601 DOI: 10.1016/0024-3205(75)90272-6 |
0.657 |
|
| 1975 |
Dingledine R, Goldstein A. Single neuron studies of opiate action in the guinea pig myenteric plexus. Life Sciences. 17: 57-62. PMID 1143011 DOI: 10.1016/0024-3205(75)90235-0 |
0.487 |
|
| 1974 |
Dingledine R, Goldstein A, Kendig J. Effects of narcotic opiates and serotonin on the electrical behavior of neurons in the guinea pig myenteric plexus. Life Sciences. 14: 2299-309. PMID 4847817 DOI: 10.1016/0024-3205(74)90111-8 |
0.557 |
|
| 1974 |
Lowney LI, Schulz K, Lowery PJ, Goldstein A. Partial Purification of an Opiate Receptor from Mouse Brain Science. 183: 749-753. PMID 4821242 DOI: 10.1126/Science.183.4126.749 |
0.323 |
|
| 1974 |
Schulz R, Cartwright C, Goldstein A. Reversibility of morphine tolerance and dependence in guinea pig brain and myenteric plexus. Nature. 251: 329-331. PMID 4473718 DOI: 10.1038/251329A0 |
0.359 |
|
| 1973 |
Dingledine R, Goldstein A. Lethality of the morphinan isomers levorphanol and dextrorphan. British Journal of Pharmacology. 48: 718-20. PMID 4788214 DOI: 10.1111/j.1476-5381.1973.tb08261.x |
0.517 |
|
| 1973 |
Goldstein A, Judson BA, Sheehan P. Cellular and metabolic tolerance to an opioid narcotic in mouse brain British Journal of Pharmacology. 47: 138-140. PMID 4717014 DOI: 10.1111/J.1476-5381.1973.Tb08167.X |
0.325 |
|
| 1971 |
Goldstein A, Lowney LI, Pal BK. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proceedings of the National Academy of Sciences of the United States of America. 68: 1742-7. PMID 5288759 DOI: 10.1073/pnas.68.8.1742 |
0.325 |
|
| 1971 |
Hahn DL, Goldstein A. Amounts And Turnover Rates Of Brain Proteins In Morphine-Tolerant Mice Journal of Neurochemistry. 18: 1887-1893. PMID 5165755 DOI: 10.1111/J.1471-4159.1971.Tb09594.X |
0.318 |
|
| 1971 |
Cheney DL, Goldstein A. Tolerance to opioid narcotics: time course and reversibility of physical dependence in mice. Nature. 232: 477-8. PMID 4937208 DOI: 10.1038/232477a0 |
0.349 |
|
| 1970 |
Richter JA, Goldstein A. Tolerance to Opioid Narcotics, II. Cellular Tolerance to Levorphanol in Mouse Brain Proceedings of the National Academy of Sciences of the United States of America. 66: 944-951. PMID 5269255 DOI: 10.1073/Pnas.66.3.944 |
0.367 |
|
| 1969 |
Sharkawi M, Goldstein A. Antagonism by physostigmine of the “running fit” caused by levorphanol, a morphine congener, in mice British Journal of Pharmacology. 37: 123-128. PMID 5824928 DOI: 10.1111/J.1476-5381.1969.Tb09529.X |
0.34 |
|
| Show low-probability matches. |